Following spinal cord injury (SCI), upper motor neuron paralysed muscles lose the normal type I (slow) and II (fast) ®bre mosaic pattern and become predominantly composed of type II (fast glycolytic) ®bres). The majority of the research demonstrating this ®bre type shift was based on pH sensitive myo®brillar ATPase staining techniques on muscle from longstanding paraplegics and quadriplegics. The purpose of this study was to describe muscle ®bre type changes over a wide time spectrum post SCI using immuno¯uorescent techniques which may be more sensitive to change. A total of 19 vastus lateralis muscle biopsy specimens were obtained from 12 SCI subjects representing time points of 0.5 ± 219 months post SCI. Fast and slow myosin heavy chain isoform distribution was determined on single muscle ®bres for each of the biopsy specimens. Early post SCI (51 month) myosin heavy chain (MCH) isoform composition remained relatively stable. A transitional period was seen between 1 and 20 months post SCI wherein there was a progressive drop in the proportion of slow MHC isoform ®bres and a rise in the proportion that co-expressed both the fast and slow MHC isoform. By approximately 70 months post SCI a new steady state had been reached characterized by almost exclusively fast MHC isoform expression. This research has demonstrated that post SCI muscle type II transformation occurs in stages and commences earlier than previously appreciated. Interventions aimed at preventing or minimizing the transformation would need to be instituted within weeks post SCI.
Introduction
Following spinal cord injury (SCI) it is well documented in humans 1 ± 9 and animals 10 ± 12 that skeletal muscles below the level of an upper motor neuron lesion undergo marked changes in their morphological, metabolic, and contractile properties. Subsequent to SCI, paralyzed skeletal muscle generally becomes atrophic, possesses lower tension generating capacity and is less fatigue resistant. Muscle histochemical and metabolic pro®le shifts toward Type II (fast glycolytic) ®bres have been well documented following SCI and may explain the problem of rapid muscle fatigability commonly encountered during rehabilitation eorts using functional electrical stimulation (FES). Knowing the time course of these adverse muscle changes is fundamental to timing interventions which may prevent or reverse the process. The remarkable plasticity of dierent properties of skeletal muscle makes the task of de®ning a temporal framework for the changes induced by SCI onerous. For example, it has been shown that some proteins (eg parvalbumin), 13 protein systems (eg sarcoplasmic reticulum ATPase), 14 or physiologic properties (eg twitch properties) 14 can be altered early in the face of perturbation to the muscle. Alternatively, other proteins (eg myosin), 15, 16 protein systems (myo®brillar ATPase), 16 or physiologic properties (eg fatigue resistance) 17 are more stable. In this regard, the majority of the studies from SCI patients have relied on a relative comparison of the histochemically determined ®bre types between normal and SCI muscle biopsies. 1, 2, 6, 7, 9 The subjective nature of ®bre typing based on saturated histochemical reaction products may be suited for muscle under steady state conditions, but is much less reliable under conditions of perturbation. 5, 18 Therefore, they may lack the sensitivity required to discern early changes in those properties determining ®bre type. Further, most studies have used patients that have been SCI for a year or more.
1,2,5,7 ± 9 As such, they provide a valuable description of the long term consequences of SCI but provide little insight into the time course of those changes.
The present study reports on a logitudinal series of muscle biopsies from four SCI patients representing 0.5 ± 3.5 months post injury. In addition, data were obtained on eight single biopsies from patients at times ranging over 1 ± 219 months post SCI. Immunofluorescence techniques were used to determine the myosin heavy chain isoform composition of single muscle ®bres. This muscle property was chosen because of its fundamental importance to muscle function and its well de®ned interrelationships with other muscle properties. 12, 19 Further, the immuno¯uorescent techniques used provide a more sensitive index of change than was possible in previous studies on SCI muscle. Our ®ndings suggest that fundamental muscle properties are altered much earlier than has been previously reported following SCI.
Method
Twelve subjects (eight males and four females) with a mean age of 22.4 years at the time of their biopsy signed informed consents to participate in this study. All had sustained traumatic spinal cord injury with complete upper motor neuron motor paralysis and sensory loss distal to the lesion level (C6-T8). Control data from 28 male and 18 female neurologically intact subjects of similar mean age from our laboratory are included for comparison.
Percutaneous vastus lateralis muscle biopsies were performed on each subject. Eight subjects had only 1 biopsy, whereas four subjects had serial biopsies. The serial biopsies were obtained over a time period of 0.5 ± 3.5 months post SCI. The subjects receiving only single biopsies represented a broader period of time post SCI (1 ± 219 months). None of the legs which were biopsied were being trained with functional electrical stimulation, although the subjects from which serial biopsies were obtained were part of another study which involved FES and weight bearing of the contralateral limb. Previous reports of FES training applied unilaterally to a paralyzed limb demonstrated no crossover eect on the contralateral limb in SCI patients. 20 Vastus lateralis muscle biopsies were performed under sterile technique without skin anesthetic using a 5 mm Bergstrom needle adapted for suction. 21 The tissue was quickly mounted on cork with OCT embedding compound, rapidly frozen in isopentane cooled in liquid nitrogen, and stored at 7708C for later analyses. Cryosections were cut at a thickness of 6 mm at 7208C using a Tissue-Tek Cryostat (Miles Laboratories), and mounted on chrome-gelatin (0.1% gelatin, 0.01% chromium potassium sulfate) coated glass coverslips. The fast and slow myosin heavy chain isoform (MHC) distribution was determined in single muscle ®bres using the immuno¯uorescence technique as described by Jiang et al. 22 Brie¯y, the coverslips were incubated for 30 min in a blocking solution containing 2% bovine serum albumin and 2% rabbit serum in phosphate buered saline (PBS), and then for 1 h with a mouse anti-chicken monoclonal antibody speci®c for slow MHC diluted 1 : 10 in blocking solution (Stockdale, Stanford). This antibody is of the IgA subclass and, although it was raised to chick slow MHC, it cross reacts with human slow MHC. After thorough washing with PBS, primary antigen-antibody complexes were labelled by incubating for 1 h in rhodamine-conjugated goat anti-mouse immunoglobulin (goat anti-mouse IgA, TRITC labelled, Sera-Lab). The sections were then washed with PBS and incubated for 1 h with a moustanti rabbit monoclonal antibody speci®c for the fast MHC (MY-32, Sigma, St. Louis, MO). This antibody is of the IgG subclass and cross reacts with human fast MHC isoforms. The sections were washed again with PBS followed by a 1 h incubation with FITCconjugated goat anti-mouse IgG antibody (FITC-goat anti-mouse IgG, Zymed Laboratories, San Francisco, CA). The coverslips were ®nally mounted on slides using Krystalon (EM Diagnostic Systems Inc., Gibbstown, NJ) mounting medium. Fluorescence was visualized on a Leitz Diplan microscope equipped with N2.1 and K2 ®lters. The N2.1 ®lter block incorporates an excitation band pass ®lter, allowing 515 ± 560 nm wavelength light to pass and a suppression long-pass ®lter allowing wavelengths longer than 580 nm to pass in order to observe the TRITC label. The K2 ®lter block incorporates an excitation band pass ®lter, allowing 470 ± 490 nm wavelength light to pass and a suppression long-pass ®lter allowing wavelengths of longer than 515 nm to observe the FITC label. The number of ®bres expressing fast, slow or combined fast and slow MHC was determined from photographs in 50 to 80 ®bres for each subject at each testing time (Figure 1 ). Table 1 contains the relative percentages of ®bres in each SCI patient biopsy which expressed only the fast or slow MHC isoform, or expressed both isoforms simultaneously. In the control subjects' vastus lateralis, the vast majority (98%) of ®bres express only one MHC isoform with a slight predominance (60%) of ®bres having only the fast MHC. Only 2% of the control muscle ®bres demonstrated co-expression of both MHC isoforms. There were no gender dierences. The signi®cant trend toward the fast ®bre type is clearly evident in the plot of Figure 2 . In patients that had been SCI for over 70 months, the vast majority of ®bres expressed only the fast MHC isoform. Thus, following long term SCI induced paralysis most ®bres in the vastus lateralis take on a new steady state pro®le de®ned by a shift in the MHC expression to the fast isoform.
Results
However, the shift to this new pro®le has interesting characteristics. In four of the six biopsies from patients that were obtained within one month of SCI there were no ®bres identi®ed that co-expressed the fast and slow MHC isoforms. In two other biopsies obtained at one month post SCI a minority of ®bres (10 and 15%) expressed both isoforms. Therefore, it appears that during the very early phase (54 weeks) post SCI paralysis, the MHC isoform remains relatively stable. In the data obtained from patients between 1 ± 20 months post SCI, there is an increase in the relative proportion of ®bres that co-expressed the fast and slow MHC isoform commencing between the ®rst and second months post SCI. Thus, ®bres undergo a transitional period during which they alter the expression of their MHC isoform presumably by down-regulation of the slow MHC and up-regulation of the fast MHC isoform. As such, there is a period of time where a single ®bre may express both MHC isoforms simultaneously, prior to achieving the new steady state characterized by a predominance of ®bres expressing only the fast MHC isoform. Although we have no information about the state of the muscle between 20 and 73 months post injury, it is apparent that a new steady state is reached by the 73 month post injury point. The kinetics of this process can be modelled, as described in the Appendix and shown in Figure 3 . Essentially, there are three states in which ®bres express only fast, only slow or both MHC isoforms. The best ®tting curves in Figure 3 assume that initially 66% of the ®bres in the muscle are slow and that there is a transition with a time constant of 4.7 months to the co-expressing state, and a further time constant of 17 months to the fast state. This model accounts for nearly 80% of the variance in the data, leaving only 20% due to variations between individuals and measurement or sampling errors. 
Discussion
The present study was undertaken in order to describe changes in the MHC isoform content of single muscle ®bres following SCI induced upper motor neuron paralysis. We obtained data over a wide range of post SCI time periods (0.5 ± 219 months) to discern how rapidly a fundamental muscle property (MHC isoform) was altered by SCI. The MHC isoform of a ®bre was chosen as a property index because of the following reasons: (1) Nearly all adult normal muscle ®bres express only one MHC isoform; 23 ( 2) The isoform composition of adult normal muscle appears to be stable; 23 (3) In normal adult muscle the MHC isoform is related to the standard histochemical based ®bre typing classi®cation criteria predicated on the pH sensitivity of myo®brillar ATPase and histochemically determined Type I ®bres have the slow MHC isoform, Type II ®bres and fast MHC isoform, and Type C ®bres co-express both MHC isoforms; 24 (4) The MHC isoform has been shown to have predicable interrelationships with other muscle properties under control conditions and in various models of muscle perturbation, 12, 19 and, (5) Immuno¯uorescence techniques are available for the determination of the MHC isoform composition of single ®bres. 22 This provides a sensitive method by which to study changes in this muscle property after SCI. Human muscle has at least three dierent MHC isoforms. 18 In this study we made no attempt to dierentiate the subpopulations of the fast MHC isoforms.
Several previous reports are available on the eects of SCI induced paralysis on human muscle. In each case they have used standard qualitative histochemical methods to ®bre type muscle biopsies at various times post SCI. In the majority of cases these studies have used patients that have been SCI for nearly one or more years. Grimby et al 1 reported that in SCI patients 10 months ± 10 years post injury the vastus Figure 2 The percentage of fast ®bres increases with time after spinal cord injury. The straight line was ®tted by the least mean squares method on this semilogarithmic plot Figure 3 The percentage of slow ®bres (top), fast ®bres (bottom) and ®bres co-expressing both slow and fast MHC can be well ®tted by a simple model that is derived in the Appendix. The ®tted curves account for nearly 80% of the variance in the data lateralis, gastrocnemius, and soleus muscles were predominately composed of Type II ®bres. Stilwill and Sahgal 2 reported that in the quadriceps (speci®c muscle not identi®ed) of three patients at least 6 months post injury the ®bre type composition remained unchanged in two patients while in the third there was a predominance of Type II ®bres. In the tibialis anterior of patients 2 ± 11 years post SCI, Martin et al 5 reported a marked increase in the relative proportion of Type II ®bres compared to control. Patients studied 15 ± 24 months post SCI by Greve et al 6 showed that in the vastus lateralis of three of four patients, Type II ®bres were the most prevalent while in one patient the majority were Type I ®bres. Round et al 7 determined that biopsies from the vastus lateralis of patients 11 months ± 9 years post SCI were composed primarily of Type II ®bres. In a recent report by Rochester et al 8, 9 patients were studied 1 ± 14 years post SCI. In six of seven patients there was a predominance of Type II ®bres found in biopsies from the tibialis anterior. In one patient the relative proportion of Type I and II ®bres was unchanged from control. Taken in total, these previous studies illustrate that longstanding paralyzed muscle appears to undergo a shift in its histochemical ®bre type pro®le toward that of a predominance of Type II ®bres. In fact, this transformation in some patients appears to be complete with no Type I ®bres evident in the biopsy. These data are essentially corroborated by our ®ndings that the patients with SCI greater than 70 months had ®bres which primarily expressed only the fast MHC isoform. Therefore, it appears that following prolonged upper motor neuron paralysis secondary to SCI, muscle ®bres that previously had Type I or slow twitch properties alter their phenotypic expression to become Type II or fast twitch.
Two studies from Scelsi and collaborators 3, 4 are of particular relevance to the present study because they also contain data from SCI patients over signi®cantly earlier time periods post injury than the aforementioned studies. Scelsi et al 3 reported that biopsies from the rectus femoris of SCI patients 1 ± 17 months post injury showed what they described as progressive stages of change. The tissue was analyzed using standard qualitative histochemical techniques. Biopsies obtained 1 ± 4 months post SCI showed no change in the relative percentage of Type I and II ®bres; however, atrophy was seen particularly in the Type II ®bres. Biopsies obtained 4 ± 9 months post SCI showed atrophy in both ®bre types with a reduction in the relative percentage of Type I ®bres. In the biopsies studied 10 ± 17 months post SCI the Type I ®bres continued to show atrophy and there was a marked increase in the relative percentage of Type II ®bres and concomitant decrease in the percentage of Type I ®bres. A later study 4 looked at the changes in the medial gastrocnemius and soleus muscles in patients 1 ± 10 months post SCI. The MHC content of the whole biopsy (in contrast to single ®bre analysis used in the present study) was estimated by electrophoretic separation techniques along with the muscle ®bre typing. The latter study concluded that in the initial 1 ± 6 months of paralysis the primary change was atrophy primarily of the Type II ®bres with no change in the relative percentage of ®bre types or MHC content. However, after 8 months there was atrophy in both ®bre types with an increase in the relative percentage of Type II ®bres and fast MHC content. In summary, these two studies suggest that the earliest changes post SCI are to the morphological muscle properties and that only after approximately 7 ± 8 months is the shift of the Type I to Type II ®bres manifested.
Our ®ndings support the concept of progressive stages of change in SCI paralyzed muscle introduced by Scelsi et al. 3, 4 However, using the sensitive technique of single ®bre MHC isoform determination, the onset of change appears to be earlier than previously described. Our data suggest that changes in the fundamental properties of muscle probably occur as early as 4 ± 6 weeks post injury. The time constant of 4.7 months indicates that 62% of the ®bres will have undergone a transformation over this period of time. Further, it appears that as the Type I ®bres change to Type II they undergo a transitional phase where they co-express slow and fast MHC isoforms. This most likely signi®es the downregulation of the slow MHC isoform and the upregulation of the fast MHC isoform in those ®bres. The mechanism may be similar to that reported to occur following chronic low frequency electrical stimulation of muscle where Type II ®bres are transformed toward Type I. A signi®cant increase in Type C ®bres which coexpress slow and fast MHC isoforms was seen in this FES model in rabbits. 24 Currently the mechanism(s) responsible for the alterations in muscle that occur following SCI are unknown. However, it does appear that not only do the ®bres atrophy rapidly post SCI 3,4 but also they begin to change their fundamental properties early post injury. From a rehabilitation perspective it would be prudent to initiate therapeutic interventions aimed at attenuating the adverse muscle impact of SCI as early as safely possible. In this regard, research is currently underway to evaluate the impact of weightbearing combined with functional electrical muscle stimulation early post SCI on muscle and bone.
